Drug Eye Africa

Kenya's PPB holds risk and crisis management workshop for board and staff

The Pharmacy and Poisons Board (PPB) of Kenya has convened a Risk and Crisis Management Workshop to strengthen institutional preparedness and proactive risk management.

PPB Chairperson Dr John Munyu, MBS, addressed Board Members, senior management and staff on 16 November 2026. He emphasised the Board’s responsibility to anticipate, identify and mitigate risks before they escalate, and stated that effective risk management must be integrated into all regulatory and operational decisions, including licensing, inspections, pharmacovigilance, procurement and digital transformation.

Dr Munyu identified five key areas requiring continuous monitoring and coordinated action: substandard and falsified medicines; operational and financial challenges; legal exposure; cybersecurity threats; and reputational risks. He called for clear documentation, assessment and ownership of institutional risks, and reaffirmed that PPB will not compromise the quality and safety of medical products.

The Chairperson further emphasised the importance of strong leadership, transparency, timely communication and collective accountability in strengthening institutional resilience, managing crises effectively and sustaining public trust.

The workshop was attended by representatives from the Gates Foundation and facilitators from PENAM.

Source: Pharmacy and Poisons Board (PPB) of Kenya, “PPB Strengthens Risk and Crisis Management to Safeguard Public Health”, 19 November 2026: https://web.pharmacyboardkenya.org/ppb-strengthens-risk-and-crisis-management-to-safeguard-public-health/

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top